Cellular morphogenesis is a fundamental developmental mechanism that governs how cells migrate, change identity, change shape, and fuse. The C. elegans male tail tip undergoes a morphogenetic event in just four cells during late L4, making this a powerful model for elucidating linkage between regulators of timing, position, and epidermal fate and the cell-biological mechanisms required for morphogenesis. Male tail tip morphogenesis (TTM) is governed by DMD-3, a conserved DM-domain transcription factor that is homologous to DMRT1, which regulates male fate in humans. Expression of
dmd-3 is necessary and sufficient for TTM to occur (Mason et al. 2008). Previous work done in the lab has shown that DMD-3 is at the center of a genetic network with a bow-tie structure, regulated by pathways including Wnt signaling and heterochronic regulation, and in turn regulating genes involved in cellular processes such as vesicle trafficking and cytoskeletal rearrangement (Nelson et al 2011). However, while some of the regulatory pathways involved in specifying DMD-3 expression are known, the structure of the network downstream of DMD-3 is uncharacterized. We are using two methods to investigate downstream targets of DMD-3: To identify tail tip-specific targets, we are performing transcriptome profiling of isolated tail tip tissue from worms that undergo tail tip morphogenesis (wild-type males and hermaphrodites ectopically expressing
dmd-3), and worms that do not (wild-type hermaphrodites and
dmd-3 mutant males). To identify direct DMD-3 transcriptional targets, we are employing chromatin immunoprecipitation and next-generation sequencing (ChIP-Seq), utilizing a CRISPR-generated
dmd-3 allele tagged with GFP and 3xFLAG. Preliminary microarray transcriptome analysis on tail tip-specific RNA identified 134 significantly differentially expressed genes in the
dmd-3 mutant relative to wild-type. Combining the results of both approaches will yield direct targets of DMD-3 that act in the male tail tip.References: Mason et al. 2008. Development 135:2373-2382. Nelson et al. 2011. PLoS Genetics 7(3):
e1002010.